The Moderna Covid-19 vaccine received full approval from the U.S. Food and Drug administration Monday, 11 months after the shot was given an emergency use authorization.
The Food and Drug Administration announced it has granted Moderna’s COVID-19 vaccine full approval for use in adults on Monday.
“The public can be assured that Spikevax meets the FDA’s high standards for safety, effectiveness and manufacturing quality required of any vaccine approved for use in the United States,” Acting FDA Commissioner Janet Woodcock said in a statement. “We are grateful to the U.S. FDA for their thorough review of our application,” she said. “We are humbled by the role that Spikevax is playing to help end this pandemic.”
In its announcement Monday, the FDA said it had seen a rare risk of heart inflammation within 7 days of a second Moderna dose, specifically in men ages 18 to 24.ANGELA WEISS/AFP via Getty ImagesANGELA WEISS/AFP via Getty Images
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Moderna's COVID-19 vaccine gets full FDA approvalModerna's COVID-19 vaccine called “Spikevax” has been given full approval from the U.S. Food and Drug Administration.
Lire la suite »
What to know about BA.2, the newest COVID-19 omicron variantIt’s called the “stealth” variant, but there’s nothing particularly stealthy about it. Researchers are working to parse whether it is a new threat.
Lire la suite »
Could there be a universal vaccine for any type of coronavirus, not just COVID-19?A pan-coronavirus vaccine will be designed using features of the virus's genetic code that are shared universally across all different versions of the virus.
Lire la suite »
Nurses Accused Of Selling Forged COVID-19 Vaccine Cards In $1.5 Million SchemeJulie DeVuono and Marissa Urrao allegedly sold vaccination cards that were obtained through DeVuono's health care practice in Long Island.
Lire la suite »